683 Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,321
| Closed | -$331K | – | 361 |
|
|
2022
Q1 | $331K | Sell |
10,321
-7,535
| -42% | -$242K | 0.02% | 213 |
|
|
2021
Q4 | $388K | Buy |
+17,856
| New | +$388K | 0.01% | 216 |
|
|
2021
Q1 | – | Sell |
-140,156
| Closed | -$2.25M | – | 256 |
|
|
2020
Q4 | $2.25M | Hold |
140,156
| – | – | 0.11% | 83 |
|
|
2020
Q3 | $1.5M | Hold |
140,156
| – | – | 0.11% | 76 |
|
|
2020
Q2 | $1.7M | Hold |
140,156
| – | – | 0.14% | 74 |
|
|
2020
Q1 | $1.38M | Buy |
+140,156
| New | +$1.38M | 0.16% | 69 |
|
|
2019
Q4 | – | Sell |
-81,874
| Closed | -$1.28M | – | 188 |
|
|
2019
Q3 | $1.28M | Buy |
81,874
+6,285
| +8% | +$98.2K | 0.14% | 61 |
|
|
2019
Q2 | $1.69M | Buy |
75,589
+17,760
| +31% | +$398K | 0.15% | 68 |
|
|
2019
Q1 | $3.96M | Buy |
57,829
+3,488
| +6% | +$239K | 0.36% | 43 |
|
|
2018
Q4 | $2.87M | Buy |
54,341
+9,341
| +21% | +$493K | 0.17% | 49 |
|
|
2018
Q3 | $3.06M | Hold |
45,000
| – | – | 0.2% | 42 |
|
|
2018
Q2 | $5.33M | Buy |
45,000
+1,523
| +4% | +$180K | 0.36% | 39 |
|
|
2018
Q1 | $3.6M | Buy |
43,477
+20,433
| +89% | +$1.69M | 0.32% | 48 |
|
|
2017
Q4 | $3.44M | Buy |
+23,044
| New | +$3.44M | 0.29% | 49 |
|